252049-05-1,
Fmoc-N-methyl-L-norvaline,
Fmoc-N-Me-Nva-OH,
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)pentanoic acid,
Fmoc-N-Me-L-2-aminovaleric acid,
L-Norvaline, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-,
L-Norvaline,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-,
(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl](methyl)amino}pentanoic acid,
Fmoc-N-Me-L-norvaline,
Fmoc-Me-Nva-OH,
fmoc-menva-oh, AldrichCPR,
N-Fmoc-N-methyl-L-norvaline,
SCHEMBL120597,
Fmoc-Nalpha-methyl-L-norvaline,
TMA050,
CTK4F5205,
DTXSID20426586,
KS-00000SU9,
ZINC2386075,
MFCD01861326,
AKOS015837160,
DS-9027,
RT-013016,
CS-0089871,
F1166,
FT-0689531,
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-norvaline,
N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-alpha-methyl-L-norvaline,
FMOC-MENVA-OH,
C21H23NO4,
ACN-033908,
CID7009909,
(2S)-2-(9H-fluoren-9-ylmethoxycarbonyl-methyl-amino)pentanoic Acid,